TILL TRANSAKTIONER
Jordbruk | Fordonsindustrin | Industriella maskiner och komponenter | TMT

Ecorobotix has completed a fundraising

Ecorobotix has raised US$52 million. The new capital will enable the company to grow into new markets, expand its product range and build on the existing commercial success of ARA in Europe.

Ecorobotix, the Swiss manufacturer of ARA, develops, produces and sells innovative farming machines that require low energy and reduce the negative ecological impact of modern agriculture, while keeping costs competitive.

Oaklins’ team in France acted as fundraising advisor in the operation.

Prata med transaktionsteamet

Antoine Lemaire

Partner
Paris, Frankrike
Oaklins France

Charlotte Delphis

Associate
Paris, Frankrike
Oaklins France

Relaterade transaktioner

Den Berk Délice accelerates growth through strategic partnership
Riskkapital | Jordbruk

Den Berk Délice accelerates growth through strategic partnership

Den Berk Délice, a leading Belgian grower of specialty tomatoes, has entered a strategic partnership with Egeria, an independent investment firm, to realize its next growth phase.

Lär dig mer
Tekova Oyj has completed a technical listing on the Nasdaq First North Growth Market Finland
Bygg- & tekniktjänster

Tekova Oyj has completed a technical listing on the Nasdaq First North Growth Market Finland

Tekova Oyj has successfully completed a technical listing (IPO) on the Nasdaq First North Growth Market Finland. This transaction marks a significant milestone in the company’s growth strategy, enhancing its visibility and access to capital markets.

Lär dig mer
Bayer AG has entered into a takeover agreement with Cara Care
Hälsovård | TMT

Bayer AG has entered into a takeover agreement with Cara Care

Bayer AG, renowned for its advancements in healthcare and life sciences, has finalized the acquisition of Cara Care (HiDoc Technologies GmbH), which entered debtor-in-possession proceedings in October 2024. Cara Care, an innovative digital health platform and official DiGA, aligns perfectly with Bayer’s strategic focus on digital health and the expansion of its innovative solutions portfolio. The transaction is expected to close in Spring 2025.

Lär dig mer